Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...

A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and ...

A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and ...

A Phase 1 clinical trial published in The Lancet has found that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treating myelomeningocele, a ...

Modern medicine has begun to recognize that the placenta can have significant medical and scientific value even after childbirth.